MedPath

Use of Mobile Teledermatology in the Care of Acne Patients

Not Applicable
Completed
Conditions
Acne
Interventions
Other: Outpatient Consultation Arm (OCA)
Other: Mobile Teleconsultation Arm (MTA)
Registration Number
NCT01399970
Lead Sponsor
Medical University of Graz
Brief Summary

The purpose of the present study is to determine whether a mobile teledermatology care model can achieve better clinical outcomes as compared to conventional, outpatient care for the management of severe acne treated with isotretinoin.

The superiority of mobile care in comparison to conventional, outpatient care will be investigated regarding

1. effectiveness: Global evaluation Acne (GEA) score -response at week 24

2. safety: drop out rates and medication side effects

3. overall patient satisfaction with acne care and therapy

4. overall physician satisfaction with mobile acne care

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
69
Inclusion Criteria

Female or male, aged 12 to 30 years

  • with facial acne
  • requiring systemic isotretinoin treatment (GEA-Score: 3-5)
  • with basic handy skills
  • with a signed consent form
Exclusion Criteria
  • Pregnancy or lactation period
  • Withdrawal of informed consent
  • Non-compliance, failure to comply with protocol requirements

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Outpatient Consultation Arm (OCA)Outpatient Consultation Arm (OCA)Conventional in Office Care
Mobile Teleconsultation Arm (MTA)Mobile Teleconsultation Arm (MTA)Mobile Teledermatology Care
Primary Outcome Measures
NameTimeMethod
Global evaluation Acne score (GEA)week 24

Change from Baseline in the median GEA score at week 24

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Dermatology, Medical University of Graz

🇦🇹

Graz, Austria

© Copyright 2025. All Rights Reserved by MedPath